Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The...
9 insider purchases on record · latest filing 2026-05-21.
Insiders have also filed 12 sale transactions at LUCD.